Literature DB >> 10841564

Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.

L K Petiniot1, Z Weaver, C Barlow, R Shen, M Eckhaus, S M Steinberg, T Ried, A Wynshaw-Boris, R J Hodes.   

Abstract

The majority of Atm-deficient mice die of malignant thymic lymphoma by 4-5 mo of age. Cytogenetic abnormalities in these tumors are consistently identified within the Tcr alpha/delta locus, suggesting that tumorigenesis is secondary to aberrant responses to double-stranded DNA breaks that occur during V(D)J recombination. Since V(D)J recombination is a recombinase-activating gene (RAG)-dependent process, we generated Rag2(-/-)Atm(-/-) mice to assess the requirement for RAG-dependent recombination in thymic lymphomagenesis. In contrast to expectation, the data presented here indicate that development of malignant thymic lymphoma in Atm(-/-) mice is not prevented by loss of RAG-2 and thus is not dependent on V(D)J recombination. Malignant thymic lymphomas in Rag2(-/-)Atm(-/-) mice occurred at a lower frequency and with a longer latency as compared with Atm(-/-) mice. Importantly, cytogenetic analysis of these tumors indicated that multiple chromosomal abnormalities occurred in each tumor, but that none of these involved the Tcr alpha/delta locus. Nonmalignant peripheral T cells from TCR-transgenic Rag2(-/-)Atm(-/-) mice also revealed a substantial increase in translocation frequency, suggesting that these translocations are early events in the process of tumorigenesis. These data are consistent with the hypothesis that the major mechanism of tumorigenesis in Atm(-/-) mice is via chromosomal translocations and other abnormalities that are secondary to aberrant responses to double-stranded DNA breaks. Furthermore, these data suggest that V(D)J recombination is a critical, but not essential, event during which Atm-deficient thymocytes are susceptible to developing chromosome aberrations that predispose to malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841564      PMCID: PMC18695          DOI: 10.1073/pnas.97.12.6664

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Chromatin remodeling directly activates V(D)J recombination.

Authors:  S R Cherry; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 2.  Developmental biology of T cells in T cell-receptor transgenic mice.

Authors:  H von Boehmer
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 3.  Ataxia-telangiectasia: closer to unraveling the mystery.

Authors:  Y Shiloh
Journal:  Eur J Hum Genet       Date:  1995       Impact factor: 4.246

4.  Evaluation of survival data and two new rank order statistics arising in its consideration.

Authors:  N Mantel
Journal:  Cancer Chemother Rep       Date:  1966-03

5.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Authors:  P Kisielow; H Blüthmann; U D Staerz; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

6.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Authors:  Y Shinkai; G Rathbun; K P Lam; E M Oltz; V Stewart; M Mendelsohn; J Charron; M Datta; F Young; A M Stall
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

Review 7.  Leukemia and lymphoma in ataxia telangiectasia.

Authors:  A M Taylor; J A Metcalfe; J Thick; Y F Mak
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

8.  Atm-deficient mice: a paradigm of ataxia telangiectasia.

Authors:  C Barlow; S Hirotsune; R Paylor; M Liyanage; M Eckhaus; F Collins; Y Shiloh; J N Crawley; T Ried; D Tagle; A Wynshaw-Boris
Journal:  Cell       Date:  1996-07-12       Impact factor: 41.582

9.  Mortality and cancer incidence in 263 patients with ataxia-telangiectasia.

Authors:  D Morrell; E Cromartie; M Swift
Journal:  J Natl Cancer Inst       Date:  1986-07       Impact factor: 13.506

10.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase.

Authors:  K Savitsky; A Bar-Shira; S Gilad; G Rotman; Y Ziv; L Vanagaite; D A Tagle; S Smith; T Uziel; S Sfez; M Ashkenazi; I Pecker; M Frydman; R Harnik; S R Patanjali; A Simmons; G A Clines; A Sartiel; R A Gatti; L Chessa; O Sanal; M F Lavin; N G Jaspers; A M Taylor; C F Arlett; T Miki; S M Weissman; M Lovett; F S Collins; Y Shiloh
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

View more
  22 in total

1.  ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.

Authors:  Karen S Hathcock; Hesed M Padilla-Nash; Jordi Camps; Dong-Mi Shin; Daniel Triner; Arthur L Shaffer; Robert W Maul; Seth M Steinberg; Patricia J Gearhart; Louis M Staudt; Herbert C Morse; Thomas Ried; Richard J Hodes
Journal:  Blood       Date:  2015-09-23       Impact factor: 22.113

2.  Sensing of intermediates in V(D)J recombination by ATM.

Authors:  Eric J Perkins; Ayyappan Nair; Dale O Cowley; Terry Van Dyke; Yung Chang; Dale A Ramsden
Journal:  Genes Dev       Date:  2002-01-15       Impact factor: 11.361

3.  Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.

Authors:  C J Williams; I Grandal; D J Vesprini; U Wojtyra; J S Danska; C J Guidos
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

4.  ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor alpha locus coding end breaks.

Authors:  Melanie S Vacchio; Alexandru Olaru; Ferenc Livak; Richard J Hodes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

5.  Involvement of the Fc gamma receptor in a chronic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of dopaminergic loss.

Authors:  Arman Lira; Jerzy Kulczycki; Ruth Slack; Hymie Anisman; David S Park
Journal:  J Biol Chem       Date:  2011-06-21       Impact factor: 5.157

Review 6.  The response to and repair of RAG-mediated DNA double-strand breaks.

Authors:  Beth A Helmink; Barry P Sleckman
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

7.  Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.

Authors:  Lori A Ehrlich; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis.

Authors:  Grace K Mahowald; Jason M Baron; Michael A Mahowald; Shashikant Kulkarni; Andrea L Bredemeyer; Craig H Bassing; Barry P Sleckman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-09       Impact factor: 11.205

9.  Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.

Authors:  William Giblin; Monalisa Chatterji; Gerwin Westfield; Tehmina Masud; Brian Theisen; Hwei-Ling Cheng; Jeffrey DeVido; Frederick W Alt; David O Ferguson; David G Schatz; JoAnn Sekiguchi
Journal:  Blood       Date:  2009-01-06       Impact factor: 22.113

10.  Histone H2AX stabilizes broken DNA strands to suppress chromosome breaks and translocations during V(D)J recombination.

Authors:  Bu Yin; Velibor Savic; Marisa M Juntilla; Andrea L Bredemeyer; Katherine S Yang-Iott; Beth A Helmink; Gary A Koretzky; Barry P Sleckman; Craig H Bassing
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.